The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of novel TACE inhibitors compatible with topical application.EBI
Nestl�
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.EBI
University Of Florida
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.EBI
Nippon Organon K.K.
Discovery and SAR of hydantoin TACE inhibitors.EBI
Merck Research Laboratories
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.EBI
University Of Athens
Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.EBI
Department Of Life Science And National Research Laboratory Of Proteolysis
Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis.EBI
Galapagos
Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis.EBI
Nestl�
In Search of Selectivity in Inhibition of ADAM10.EBI
University Of Notre Dame